 An evaluation of risk analysis as applied to agricultural biotechnology (with a case study of gmo labeling)Agribusiness, 2000, vol. 16, issue 1, 115-123 Abstract: Governments have several policy instruments available for influencing the speed of adoption of agricultural biotechnology and the ultimate market share of products produced with its use. Differences between countries in rates of and conditions on regulatory approval of agricultural biotechnologies result from different approaches to the factors included in risk analysis andthe inclusion of different factors. Differences in labeling policy result from these same sources, as well as from different views of the consumer's right to know about how a product was produced. An economic evaluation of the use of risk analysis to regulate agricultural biotechnology and products derived from it focuses on the welfare effects of the policy chosen relative to those of alternative policies that could have been chosen. The full application of benefit|cost analysis in different countries may indicate that different policies best suit their varying situations. [EconLit Subject Codes: K2, F1, Q1] © 2000 John Wiley & Sons, Inc. Date: 2000 There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:wly:agribz:v:16:y:2000:i:1:p:115-123 DOI: 10.1002/(SICI)1520-6297(200024)16:1<115::AID-AGR9>3.0.CO;2-M Access Statistics for this article Agribusiness is currently edited by Ronald W. Cotterill More articles in Agribusiness from John Wiley & Sons, Ltd. |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.